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Abstract
Objective The collection of lung fluid using a suction catheter
(s-Cath) and non-bronchoscopic bronchoalveolar lavage
(mini-BAL) are two minimally invasive methods of sampling
the distal airspaces in patients with the acute respiratory
distress syndrome (ARDS). The objective of this study was to
determine the similarity of the lung fluid samples recovered
by these methods using proteomic analysis.
Methods Distal lung fluid samples were collected from
seven mechanically ventilated patients with ARDS using
both s-Cath and mini-BAL in each patient and compared
using two-dimensional difference gel electrophoresis. Pro-
tein spots of interest were identified using matrix-assisted
laser desorption/ionization time-of-flight mass spectrometry.
Main Results An average of 2,164 spots was detected in the
s-Cath and mini-BAL samples. Of these, 68.4% of the
protein spots were similar between the s-Cath and mini-
BAL samples, 13.2% were increased in s-Cath compared to
mini-BAL, and 18.4% were decreased in s-Cath compared
to mini-BAL. For each of the seven subjects, overabun-
dance analysis showed that the actual number of differen-
tially expressed spots in the mini-BAL and s-Cath sample
was more than the expected number if the samples were
identical. There were nine proteins that were consistently
differentially expressed between the mini-BAL and s-Cath
samples. Of these nine proteins, five are abundantly found
in neutrophils or airway epithelial cells, suggesting that the
s-Cath may sample the bronchial airways to a greater extent
than mini-BAL.
Conclusion Proteomic analysis of mini-BAL and s-Cath
samples shows for the first time that, although these two
methods for sampling the lungs of critically ill patients are
generally similar, the s-Cath method oversamples the distal
airways compared to the mini-BAL method.
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Introduction
Studies of the mechanisms of acute lung injury (ALI) and
the acute respiratory distress syndrome (ARDS) have relied
heavily on analyses of fluid from the distal airspaces of
humans and animals with normal and injured lungs. The
major methods of sampling the cells, proteins, and other
constituents of the airspaces include direct collection of
edema fluid from the distal airways using a long suction
catheter (s-Cath), the use of a suction catheter with an
occlusive tip through which a small volume of fluid is
instilled and then aspirated (mini-BAL), and directed
fiberoptic bronchoscopy with bronchoalveolar lavage in a
specific lung region, such as the right middle lobe or
lingula (bronchoscopic-BAL). The s-Cath and the mini-
BAL methods are advantageous because they are safe,
inexpensive, and easy to perform. In contrast, bronchosco-
py is more frequently associated with complications such as
respiratory deterioration, is more expensive, and requires
highly trained personnel. Importantly, relatively little is
known about how these methodologies compare in sam-
pling the distal airspaces.
The s-Cath method was developed and validated by
Matthay and Wiener-Kronish [1] and has the advantage of
recovering undiluted edema fluid that moves up from the
alveolar space into the distal airways. Micropuncture studies
in animals have shown that this fluid accurately reflects
alveolar fluid composition under experimental conditions [2,
3]. However, patients with lung injury typically have
recoverable lung edema only at the onset of illness, so this
method is not suitable for studying sequential changes over
time. The mini-BAL method was developed to enable
sampling of the distal airspaces regardless of whether or
not edema fluid is present in the airways. In this method, a
specialized dual lumen catheter is advanced through the
endotracheal tube until it occludes the distal airway, then a
small volume of 0.9% NaCl is instilled into the distal lung
segment and recovered by aspiration. This method can be
used to sample the distal airspaces repeatedly, as long as the
patient remains intubated.
The essential problem in comparing studies using these
two minimally invasive methodologies is that their compa-
rability in recovering airspace cells and proteins has not
been investigated. Because the mini-BAL method involves
instilling fluid into the lungs, it is possible that the mini-
BAL method samples a different ‘space’ than the s-Cath
method. Therefore, the purpose of this study was to assess
the similarity between the lung fluids obtained by s-Cath
and mini-BAL. We performed a proteomic analysis of distal
lung fluids obtained by both techniques in patients with
ARDS based on the premise that comparing the global
protein content in the lung fluids obtained by each method
would be a relevant measure of the similarity between these
lung fluid samples. Furthermore, examining the character-
istics of the proteins that are differentially recovered by
each technique could reveal underlying sampling biases.
Materials and Methods
Patient Population
Patients admitted to the multidisciplinary intensive care unit
at Regional Hospital, Locarno, Switzerland between 2001
and 2003 were eligible for inclusion. All subjects were
prospectively identified as having ALI/ARDS by the
American–European Consensus Conference definition [4,
6]. Clinical and physiologic indices of disease severity were
recorded using a standardized data collection form. The
human study protocol was approved by the Ethical
Committee of Human Research of Canton Ticino, Switzer-
land. The use of the lung fluid samples for proteomic
analysis was approved by the Institutional Review Board of
the University of Washington. Informed consent was
obtained from the patient or legal representative.
Sample Collection
All patients were intubated and mechanically ventilated at
the time of sample collection. Distal lung fluid samples
were obtained from each subject using both the s-Cath and
mini-BAL techniques within 5 h of intubation. The s-Cath
was performed using a 14-Fr tracheal suction catheter. The
catheter was blindly advanced through the endotracheal
tube until it was wedged into a distal airway. Gentle
aspiration without saline instillation was used to collect
lung fluid samples as previously described by Matthay and
Wiener-Kronish [1]. The mini-BAL samples were collected
using a dual lumen catheter (16-Fr 5 mm outer catheter, 12-F
inner catheter, BAL Cath, Ballard Medical Products, Draper,
Utah, USA) that was blindly introduced into the airways via
the endotracheal tube. The inner catheter was advanced into
a distal wedge position, and five separate aliquots of 30 ml of
sterile 0.9%NaCl were serially instilled and gently suctioned
from the distal airways. Mini-BAL samples were obtained
by the local investigators, whereas s-Cath samples were
obtained by either an investigator or a trained critical care
nurse. All samples were immediately processed by an
investigator.
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Sample Preparation
All samples were filtered through a 100-μm nylon cell
strainer (Falcon 2360, Becton Dickinson, Frankling Lakes,
NJ, USA). An aliquot of the sample fluid was used for cell
counts obtained manually with a hematocytometer. A
portion of the cell-free supernatant was frozen at −80°C
and sent to the VA Puget Sound Pulmonary Research
Laboratories (Seattle, WA, USA) for proteomic studies.
For proteomic analysis, all samples were concentrated to
equivalent starting volumes (approximately 500 μl) using a
5 kDa molecular weight filter (Amicon Ultra-15, Millipore,
MA, USA). The samples were then spun through a 0.22-μm
filter to remove mucus and other insoluble products. The
total protein concentrations were determined using the BCA
Protein Assay (Pierce, Rockford, IL, USA).
To improve the detection of low-abundance proteins in
proteomic analysis, all samples were depleted of six highly
abundant serum proteins (albumin, transferrin, haptoglobin,
antitrypsin, IgG, IgA) using a monoclonal IgG immunoaf-
finity high-performance liquid chromatography column
(Multiple Affinity Removal System, Agilent Technologies,
Wilmington, DE, USA). Approximately 1,500 μg of lung
fluid protein was applied to the column. The flow-through
fractions containing the unbound, low-abundance proteins
were collected for further analysis. When lung fluid
samples exceeded 1,500 μg of total protein, sequential
injections onto the column were performed, and the flow-
through fractions were pooled. The high-abundance pro-
teins that were depleted from the lung fluids were eluted
from the immunoaffinity column and analyzed using the
same methodology as the flow-through fraction containing
the low-abundance proteins.
Following the depletion of high-abundance proteins, the
buffer of the flow-though fraction was replaced with a
buffer containing 7 M urea, 2 M thiourea, 4% CHAPS, and
10 mM tris at pH 8.5. The flow-through fraction was then
concentrated to approximately 100 μl using a 5-kDa
molecular weight filter (Amicon Ultra-4, Millipore, MA,
USA). The final protein concentration was measured using
the 2D-Quant Assay (Amersham Biosciences, Piscataway,
NJ, USA), which allows protein measurements in urea-
based solutions.
Two-Dimensional Difference Gel Electrophoresis
Proteins in the lung fluid samples were analyzed using two-
dimensional difference gel electrophoresis (DIGE, Amer-
sham). In the DIGE method, fluorescent dyes with unique
absorbance and emission spectra (Cy2, Cy3, Cy5) are used
to differentially label a reference standard (a pooled
collection of all the samples used in the experiment) and
up to two experimental samples. The aliquots of the labeled
standard and each labeled experimental sample are then
mixed and run in a single two-dimensional gel in which
proteins are separated first by their isoelectric points (first
dimension) and then by molecular weights (second dimen-
sion). The gel is scanned at three different wavelengths to
identify the proteins labeled with Cy2, Cy3, and Cy5, and
the images are then superimposed. The abundance of the
individual protein spots in the experimental samples are
expressed as a ratio between the spot of interest (Cy3 or Cy
5 label) and the corresponding spot in the reference
standard (Cy2 label). The pooled standard is run with the
samples of interest in each gel to minimize the experimental
variability associated with gel-to-gel comparisons [5].
For each subject, 50 μg of pooled standard, 50 μg of
fluid from s-Cath, and 50 μg of fluid from mini-BAL were
labeled using Cy2, Cy3, and Cy5, respectively, to create a
single sample containing a mixture of the three different
labeled samples. These samples were then applied onto a
single rehydrated immobilized pH gradient (IPG) strip
pH 4–7, 24 cm (Amersham). For first-dimensional electro-
phoresis, voltage was applied at 200 V for 3 h, increased
linearly from 300 to 8,000 V for 12 h, and maintained at
8,000 V for 4 h. The IPG strip was removed and
equilibrated in a buffer containing 100 mM tris (pH 8.0),
6 M urea, 35% v/v glycerol, 2% w/v sodium dodecyl sulfate
(SDS), and 32 mM dithiothreitol (DTT). The strip was then
equilibrated a second time with the same solution except
that the DTT was replaced with 0.24 M iodoacetamide. The
strip was then applied onto a 21×27 cm low-fluorescence,
12.5% SDS gel. The gel was run at a power of 5 W for
30 min, then at 20 W for approximately 5 h using the Ettan
Dalt Twelve System (Amersham). To identify individual
protein spots, the gels were scanned using the GE Health-
care Typhoon 9400 Series Variable Imager with excitation
wavelengths of 526 nm for Cy2, 532 nm for Cy3, and
580 nm for Cy5. This procedure was performed using the
samples from each of the seven subjects, yielding a total of
seven gels, each containing the s-Cath and mini-BAL
sample for one patient and the standard sample consisting
of a mixture of all proteins in all samples.
Protein Spot Analysis
Each gel contained spots from the pooled standard (Cy2
wavelength), s-Cath (Cy3), and mini-BAL (Cy5). By
scanning the gel at the excitation wavelengths for each
fluorescent dye, comparisons between the protein spots in
the standard (Cy2) and the samples of interest (Cy3,5) were
made. The abundance of each of the protein spots in the
experimental samples was expressed as a ratio between the
spot of interest in the s-Cath and mini-BAL sample (Cy3 or
Cy 5 label) and the corresponding spot in the reference
standard (Cy2 wavelength). We performed initial studies
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using samples containing known amounts of proteins and
found that the lower limit of detection and protein
identification in the DIGE method is approximately 50–
70 ng (data not shown). Protein spot detection and spot
abundance comparisons were performed using the Decyder
software program version 5.01 (Amersham). The difference
in-gel analysis (DIA) module of the Decyder program was
used to detect differences in the abundance of the individual
spots between the s-Cath and mini-BAL samples for each
subject (Cy3/Cy2 vs Cy5/Cy2, pairwise comparison). A
significant difference in spot abundance was defined as a
twofold change in the log (volume) ratio. The Student’s t
test was used for comparison with a p<0.05 for statistical
significance. The pairwise comparison was used to measure
the number of spots that were differentially expressed
between the s-Cath and mini-BAL samples. Following the
pairwise comparison, an overabundance analysis was
performed for each patient by comparing the actual number
of differentially expressed spots detected in the pairwise
analysis with the calculated number of differentially
expressed spots expected if the mini-BAL and s-Cath
samples were equivalent at a significance of p<0.05. The
expected number of differentially expressed spots, which is
an estimate of the number of differentially expressed spots
caused by chance alone, was calculated by multiplying the
number of spots detected in the mini-BAL and s-Cath
sample for each patient by the p value 0.05. The pairwise
comparison and the overabundance analysis were used to
measure the degree of similarity between the s-Cath and
mini-BAL samples for each subject.
Next, the biological variance analysis module of the
Decyder program was used to group protein spots found in
mini-BAL samples across the seven subjects and to
compare them to those spots found in s-Cath samples from
the same subjects (group-wise comparison). Only the spots
that were detected in at least six out of seven mini-BAL and
s-Cath samples were included in the group-wise compari-
son. Significant differences in spot abundance were
calculated using Student’s t test (p<0.05). The group-wise
comparison was used to find protein spots that were
consistently different between the mini-BAL and s-Cath
samples.
Identification of Protein Spots
Protein spots that were differentially expressed between the
mini-BAL and s-Cath samples in the group-wise analysis
were excised using an automated spot picker (Ettan DIGE
Spot-picker, Amersham) with a 2-mm picking head and
placed in a 96-well ZipPlateC18 (Millipore, MA, USA) for
in-gel digestion and analysis using matrix-assisted laser
desorption mass spectrometry (MALDI). Each gel spot
containing a protein of interest was washed, dehydrated,
and digested with trypsin in 50 μl of 50 mM NH4HCO3
and 5 mM CaCl2 (27). The peptides were eluted from the
ZipTip of the plate in 80% acetonitrile containing 0.1%
trifluoroacetic acid (TFA), spotted on the MALDI target
(0.5 μl), dried, and overlaid with 0.5 μl of !-cyano-4-
hydroxycinnamic acid matrix (5 mg/ml in 70% acetonitrile,
0.1% TFA) for matrix-assisted laser desorption/ionization
time-of-flight (MALDI-TOF)/TOF mass spectrometry. The
MALDI-TOF MS and MS/MS spectra were acquired on the
ABI 4700 proteomic analyzer MALDI tandem TOF mass
spectrometer (Applied Science, Foster City, CA, USA) with
air as the collision gas. The MS and MS/MS spectra were
searched in combination against the human SwissProt protein
database using the Mascot search engine. A cutoff of total
peptides >5 and uniques peptides >2 was used for protein
identification. Only protein identifications with a confidence
interval greater than 95% were further considered.
Statistical Analysis
The clinical characteristics of the study subjects are reported
as the mean ± SD. Comparisons between the characteristics
of the lung fluid samples were made using an unpaired, two-
tailed t test. Differences in the abundance of protein spots
were determined using the Decyder software program
version 5.01 (Amersham) as described above. The proteins
in the spots were identified by comparing the spectra
obtained from mass spectrometry to the SwissProt protein
database. Significance levels were set at a p<0.05.
Results
Patient Characteristics
The baseline clinical characteristics and the risk factors for
ARDS of the seven patients included in the study are
summarized in Table 1. The patients were male with a mean





Lung injury score (LIS) 2.3±0.5
SAPS II 55±20.3
ICU mortality (%) 2/7 (28.6)
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age of 54 years. There were several different risk factors for
ARDS, with pneumonia being the most common (three out
of seven). The characteristics of the lung fluids obtained by
s-Cath and mini-BAL obtained in these patients are
summarized in Table 2. The cell count for one of the
s-Cath samples could not be obtained because of low
sample volume. The s-Cath samples had significantly more
white blood cells than the mini-BAL samples (p<0.05).
Although the percentage of neutrophils was higher in the
s-Cath samples, it did not reach statistical significance (p=
0.192). In addition, four out of seven the s-Cath samples
contained bronchial epithelial cells compared to two out of
seven mini-BAL samples. The protein concentration of the
s-Cath samples was approximately 16-fold greater than the
mini-BAL samples (p<0.05).
Depletion of High-abundance Proteins
Before proteomic analysis, the lung fluids obtained by both
s-Cath and mini-BAL were depleted of six high-abundance
proteins (albumin, anti-trypsin, haptoglobin, transferrin,
IgA, IgG) using an immunoaffinity column. Depletion of
high-abundance proteins improved the detection of the
number of low-abundance protein spots by at least threefold
(undepleted vs low-abundance fractions, Fig. 1). The high-
abundance fraction was analyzed to assess the inadvertent
depletion of low-abundance proteins. Nineteen spots in the
high-abundance fraction could not be assigned to one of the
high-abundance proteins based on their location on the gel.
These spots were excised and identified by mass spectrometry.
Fifteen of the 19 spots were identified as one of the six high-
abundance proteins depleted by the immunoaffinity column.
Four protein spots in the high-abundance fraction were not
among the six proteins that are depleted by the column (Fig. 1).
Spot Analysis
To determine whether the lung fluid samples collected by
the s-Cath and mini-BAL were equivalent, the protein
profiles in the fluid obtained by each technique in the same
patient were compared using DIGE. On average, 2,164
spots were detected in the spot analysis (Table 3). These
spots were used for pairwise comparison of protein
abundance in the mini-BAL and s-Cath samples from each
subject. The similarity in spot abundance was used as a
measure of the agreement between the samples obtained by
each method. Figure 3 shows a gel from one representative
subject that demonstrates how this comparison was made
using DIGE.
The differences in spot abundance between the s-Cath
and mini-BAL fluids in each of the seven subjects are
summarized in Table 3. On average, the abundance of
68.4% (±8.9%) of the protein spots was equivalent for each
subject. In contrast, the abundance of 31.6% of the protein
spots was different in the s-Cath vs mini-BAL samples in
each patient. Of these, 13.2% (±7.1%) of the protein spots
were increased in s-Cath compared to mini-BAL, and
18.4% (±4.8%) of the proteins spots were decreased in
s-Cath compared to mini-BAL. To evaluate the experimen-
tal variability in our analysis, identical s-Cath samples were
labeled with Cy3 and Cy5 and run on a single gel (Fig. 2).
The overlap image in Fig. 2 shows that the location of the
protein spots is not affected by whether they are labeled
with Cy3 or Cy5. Furthermore, the spot analysis program
(Decyder) correctly identified all 2,257 detected spots as
similar in abundance (Fig. 2). In contrast, when s-Cath and
mini-BAL were run in the same DIGE analysis, many spots
differed (Fig. 3).
The number of differentially expressed spots in the
s-Cath and mini-BAL sample was compared with the
calculated number of differentially expressed spots
expected if the s-Cath and mini-BAL samples were
equivalent (overabundance analysis). This analysis showed
that the actual number of different spots in the mini-BAL
and s-Cath sample was more than the expected number for
each of the seven subjects (Fig. 4). On average, there was a
sevenfold increase in the actual number of differentially
expressed spots as compared with the calculated number.
The minimum difference was a fourfold increase (sample 1,
Fig. 4), whereas the maximum difference was nearly a 12-
fold increase (sample 2, Fig. 4).
Because of the overabundance of differentially expressed
spots between the s-Cath and mini-BAL samples, the next
step was to perform a groupwise comparison to determine
whether there were consistent differences in the protein spots
found in the s-Cath vs mini-BAL samples. Seven hundred
five protein spots were detected in both the mini-BAL and
s-Cath fluids of six out of seven subjects and were used for
the groupwise comparison (Fig. 5). Of the 705 spots, 17
(2.4%) were differentially expressed in s-Cath vs mini-BAL
samples. All of the 17 spots were increased in the s-Cath
samples as compared with the mini-BAL samples.






White blood cells (per
microliter of sample fluid)
2067±1193 771±642 0.047
Neutrophils (%) 82±19 66±23 0.192
Macrophages (%) 14±18 29±24 0.227
Lymphocytes (%) 2.8±1.7 3.6±2.8 0.527
Eosinophils (%) 1.0±1.2 1.0±1.6 0.443
Epithelial cells 4/7 2/7
Protein concentration (g/dl) 25.3±22.3 1.6±2.0 0.048
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Protein Identification
Sixteen of the 17 spots that were consistently increased in
the s-Cath vs mini-BAL samples were identified by mass
spectrometry (Fig. 6, Table 4). One of the 17 spots could
not be identified because the protein content in the spot was
below the level of detection of the mass spectrometer.
Several of the spots were identified as the same protein,
which could be explained by protein fragmentation or post-
translation modification (Fig. 6). The 16 spots that were
identified represented a total of nine different proteins
(Table 4). For comparison, 15 other protein spots that were
similar between s-Cath and mini-BAL fluids were also
excised and identified (Table 4).
Discussion
The development of non-invasive lung sampling techniques
is important for both patient care and research. Before these
techniques are routinely used, however, their biases and
limitations must be defined. Currently, two noninvasive
methods to sample the distal lung fluid (s-Cath and mini-
BAL) are available. Global patterns of protein expression in
the lung fluid can be used as “protein fingerprints” to study
the degree of similarity between the samples obtained by
these collection techniques. Thus, the goal of our study was
to use proteomic analysis to determine [1] whether or not
the samples obtained by these methods are interchangeable
and [2] whether the differences in the proteins collected by
the two techniques reveal any sampling biases.
In biological fluids, the presence of high-abundance
proteins often limits the detection of biologically important
low-abundance proteins [7, 8]. Thus, before performing
proteomic analysis, we depleted all lung fluid samples of
six high-abundance serum proteins using an immunoaffin-
ity column. We detected an average of 2,164 spots detected
per sample. Prior studies by Bowler et al. [28] using 2D-
electrophoresis on s-Cath samples from patients with
ARDS detected approximately 300 spots per sample.
Noel-Goeris et al. [29] attempted to comprehensively
Table 3 Summary of protein spot analyses between s-Cath and mini-











1 1,992 79.2 4.4 16.4
2 2,417 51.1 24.5 24.4
3 2,637 67.5 19.4 13.1
4 1,951 67.5 6.9 25.6
5 2,148 73.0 12.3 14.7
6 1,810 66.4 15.5 18.1
7 2,190 74.1 9.5 16.4
Mean
(±SD)
2,164±285 68.4±8.9 13.2±7.1 18.4±4.8
A difference in spot abundance was defined as a twofold change in log
volume ratio. The Student’s t test was used for comparison with a p<
0.05 for statistical significance.
Fig. 1 High-abundance protein depletion of lung fluid samples. Two-
dimensional electrophoresis of undepleted ARDS lung fluid samples
is limited by the presence of high-abundance serum proteins.
Depletion of these proteins using an immunoaffinity column resulted
in a threefold improvement in detection of low-abundance proteins.
The high-abundance protein fraction was analyzed for the presence of
low-abundance proteins. Only four protein spots representing three
low-abundance proteins were found in the high-abundance fraction
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identify all proteins present in the human bronchoalveolar
lavage fluid (BALF) using 2D-electrophoresis and detected
over 1,200 spots using silver staining. Schnapp et al. [30],
using a more sensitive mass-spectrometry-based shotgun
proteomics approach, were able to identify approximately
200–650 proteins in the BALF of patients with ARDS. Our
results show that, compared to earlier studies, using 2D-
electrophoresis on BALF, depletion of high-abundance
proteins by immunoaffinity depletion dramatically
improves the resolution of low-abundance proteins. We
chose to use the multiple affinity removal system (MARS)
immunoaffinity column (Agilent) because previous studies
have shown that MARS has a favorable sensitivity and
specificity as compared with other methods of depleting
high-abundance proteins [7]. We also analyzed the column
fraction that contained the high-abundance proteins to
determine the extent to which low-abundance proteins were
also depleted as a result of protein–albumin interactions or
non-specific binding to the immunoaffinity column. Only
four low-abundance protein spots representing three pro-
teins were detected in the high-abundance fraction that
eluted from the column. In initial experiments, we tested
the reproducibility of our depletion method (data not
shown). Using 45 BALF samples from normal and ARDS
subjects, we found that approximately 18% (SD, 6.1%) of
the proteins from the BALF consistently remain in the
original sample after high-abundance protein depletion.
Thus, the column appears to reproducibly deplete the same
proportion of high-abundance proteins across many sam-
ples with low variability. We also performed high-abun-
dance depletion on three identical aliquots of pooled BALF
samples and found that greater than 85% of the spots were
Fig. 2 Assessment of experi-
mental variability in proteomic
analysis. Identical s-Cath sam-
ples were labeled with Cy3 (a)
and Cy5 (b), and run on a single
gel. A total of 2,257 spots were
detected in the overlapped im-
age. All 2,257 spots were found
to be similar between the Cy3
and Cy5 images by the Decyder
program (c). In the overlapped
image, spots that are similar
between Cy3 and Cy5 are yel-
low. Spots that are increased in
Cy3 and in Cy5 are green and
red, respectively
Fig. 3 Detection of differences in protein spot abundance between s-
Cath and mini-BAL samples using 2D DIGE. The s-Cath and mini-
BAL samples for each patient were labeled with different fluorescent
dyes and run on a single gel. The protein spots in each sample were
detected separately using the unique excitation/emission character-
istics of the dyes (a and b). The differences in protein spot abundance
were quantitated using an overlapping image (c). In the overlapping
image, proteins spots with similar abundances between s-Cath and
mBAL are yellow. Spots that are more abundant in s-Cath are green.
Spots that are more abundant in mBAL are red
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similar in the high-abundance fractions. This suggests that
the majority of the proteins that are depleted by the column
during each run are the same. In addition, two identical
ARDS BALF samples were depleted separately and run on
separate DIGE gels. More than 92% of the spots were
similar between the two samples, suggesting that the
variability in the overall methodology, including the high-
abundance protein depletion, is small. Our results show
that, while some low-abundance proteins may be depleted
along with the high-abundance proteins, these losses are
minor and are outweighed by the improvement in the
resolution of the other low-abundance proteins.
After the s-Cath and mini-BAL samples were depleted of
high-abundance proteins, we performed proteomic analysis
to compare their global protein content. The abundance of
the protein spots in the s-Cath and mini-BAL samples
obtained from each patient was compared to assess the
interchangeability of the sampling techniques (pairwise
analysis). The results of this pairwise analysis showed that
there was significant variability in how similar the samples
were across the seven subjects (79% maximum similarity,
51% minimum similarity). Overall, the similarity of the






















Fig. 4 Overabundance analysis of the actual and expected number of
protein spots that differ between s-Cath and mini-BAL using p<0.05.
The actual number of differentially expressed spots is greater than
would be expected by chance for each of the seven subjects
Fig. 5 Differentially expressed
protein spots between s-Cath
and mini-BAL samples. Seven
hundred five spots (a and b)
were present in six out of seven
gels and were used for group-
wise comparison between the s-
Cath and mini-BAL samples. Of
these, 17 spots were differen-
tially expressed (c and d). All 17
spots were overexpressed in the
s-Cath samples. e) and f Mag-
nified images of one of the 17
spots in 2D and 3D views. The
volume of the 3D cone is related
to protein abundance in the spot.
Significant differences in spot
abundance were calculated us-
ing the Student’s t test (p<0.05)
Clin Proteom (2007) 3:30–41 37
similarity between the samples in each patient, we
calculated the expected number of differentially expressed
spots, assuming that the samples were equivalent (at p<
0.05), and compared the result to the actual number of
differentially expressed spots in each patient. This over-
abundance analysis showed that there were many more
differentially expressed spots than would be expected if the
s-Cath and mini-BAL samples were interchangeable. This
difference was consistent, as it was found in all seven
subjects. It was also robust, with a minimum of a fourfold
increase in the number of differentially expressed spots.
Thus, based on the differences in the global protein content,
the lung fluids obtained by the s-Cath and mini-BAL have
some important differences.
To explore these differences, we performed a group-wise
analysis to study the proteins that are preferentially found in
either the s-Cath or mini-BAL samples. We found 17
protein spots (representing nine proteins), which were
consistently different between the s-Cath and mini-BAL
samples. Among these proteins, two interesting patterns
emerged. First, all of the protein spots that were different
between s-Cath and mini-BAL were over-expressed in the
s-Cath samples. Based on this observation, we speculated
that some of these proteins came from a compartment in the
lung that is over-sampled by the s-Cath relative to the mini-
BAL. Second, four out of the nine proteins that were over-
expressed in the s-Cath sample were proteins found in
neutrophils (calgranulin A/B, annexin A3/A5) [9–14].
Calgranulin A and B are abundant in the cytoplasm of
neutrophils and have been implicated in the regulation of
inflammation [9]. Similarly, annexin A3 is expressed
almost exclusively in the cytosol of myeloid cells and
may have a role in vascular endothelial growth factor-
mediated angiogenesis [10, 11]. Annexin A5 is more
ubiquitously expressed but is found in leukocytes and at
sites of cellular injury and apoptosis [13, 14]. Taken
together, these proteins account for over 40% of the
cytosolic proteins in neutrophils [9, 12]. Furthermore, this
result is consistent with the cell counts in the s-Cath and
mini-BAL samples, which showed a trend toward a greater
percentage of neutrophils in the s-Cath compared to mini-
BAL samples (Table 2). These findings suggest that, as
compared with the mini-BAL method, the s-Cath method
tends to sample a compartment in the lung where
neutrophils are more abundant.





Proteins differentially expressed in s-Cath compared to mini-BAL
1 Transthyretin precursor 96
2 Calgranulin B (S100A9, MRP-14) 100
3 Calgranulin B (S100A9, MRP-14) 100
4 Calgranulin B (S100A9, MRP-14) 99
5 Calgranulin B (S100A9, MRP-14) 99
6 Calgranulin B (S100A9, MRP-14) 100
7 No match N/A
8 Tyrosine protein kinase ZAP-70 92
9 Calgranulin A (S100A8, MRP-8) 100
10 Calgranulin A (S100A8, MRP-8) 100
11 Calgranulin A (S100A8, MRP-8) 100
12 Calgranulin A (S100A8, MRP-8) 100
13 Annexin A5 100
14 Annexin A3 100
15 Squamous cell carcinoma antigen 1 100
16 Apolipoprotein A1 100
17 Hemoglobin beta chain 100
Proteins similar in s-Cath and mini-BAL
18 Haptoglobin 100
19 Alpha 1 antitrypsin 100
20 IgA (heavy chain) 100
21 Erythrpoietin precursor 98
22 Leukocyte elastase inhibitor 95
23 MAP3K12 binding inhibitory protein 99
24 Rab GDP dissociation inhibitor 100
25 Pescadillo homolog 1 (Pes1) 97
26 Haptoglobin 100
27 Fibrinogen (gamma chain) 100
28 Alpha 1 antichymotrypsin 100
29 Complement C4 100
30 Serum amyloid protein component 100
31 Complement C4 100
32 Heat shock protein 1 100
A cutoff of total peptides >5 and unique peptides >2 was used for
protein identification.
Fig. 6 The 17 spots that were differentially expressed in s-Cath vs
mini-BAL were excised for mass spectrometry. In addition, ten spots
that were similar between the two groups were analyzed for
comparison. The protein identifications made by mass spectrometry
are shown in Table 4
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The observation that neutrophils are more represented in
the airways than the alveolar space was first reported in
studies of patients with chronic bronchitis, in which the
analysis of sequential bronchoalveolar lavage aliquots
showed that the neutrophil recovery was greatest in the
first lavage aliquot [15]. Subsequently, Rennard et al. [16]
showed that the cell content of lung fluid varies according
to the segment of the lung sampled. Specifically, the
bronchial airway fractions contained significantly more
neutrophils and epithelial cells than the alveolar fractions
[16]. These findings have been reproduced in lung diseases
that cause a neutrophilic alveolitis including idiopathic
pulmonary fibrosis [17], as well as other parenchymal lung
diseases such as sarcoidosis [18]. Collectively, these studies
suggest that lung fluid originating from the bronchial
airways contains more neutrophils as compared with lung
fluid from the alveoli. Thus, the overexpression of
neutrophil proteins in s-Cath fluid compared to mini-BAL
fluid in the same patient suggests that s-Cath samples the
bronchial airways to a greater extent than does mini-BAL.
This is further supported by the over-expression of a protein
found exclusively in airway epithelial cells in the s-Cath
samples, squamous cell carcinoma antigen-1 (SCCA-1).
SCCA-1 is a serpin proteinase inhibitor that was originally
isolated in human cervical squamous cell carcinomas [19].
It has since been found to be expressed in normal human
bronchial epithelium and may be overexpressed in inflam-
matory airways diseases such as asthma [24]. Furthermore,
bronchial epithelial cells were found in four out of seven
s-Cath samples as compared with only two out of seven
mini-BAL samples (Table 2).
Prior studies using micropuncture methods in experi-
mental animals have shown that edema fluid sampling via
the s-Cath method reflects alveolar fluid [2, 3]. However, it
is well recognized that all endoluminal methods of
sampling the distal lung spaces, whether it be s-Cath,
mini-BAL, or bronchoscopic BAL, contain some airway
contents. What is not known is how much relative airway
contamination is there in each of these types of samples.
Our results show that s-Cath samples the bronchial airways
to a greater extent than mini-BAL. One plausible explana-
tion for this finding relates to the method of collecting the
lung fluid with each technique. The s-Cath collects lung fluid
directly without the instillation of 0.9% NaCl. Thus, a larger
proportion of the fluid sampled will come from the area
immediately beyond the catheter tip, reflecting the airways.
With the mini-BAL method, on the other hand, the instilled
fluid is likely to flow into the alveolar spaces so that the fluid
that is recovered (especially the later aliquots) is likely to
reflect the alveolar contents to a greater degree.
Although the instillation of 0.9% NaCl may improve the
recovery of alveolar contents in lung fluid samples, one
disadvantage is that the lung fluid samples become diluted
compared to s-Cath samples [25, 26]. Miller et al. [25]
compared the protein concentrations of ARDS lung fluids
collected by s-Cath (N=17) to lung lavage samples collected
by bronchoscopic BAL (N=19) and found that the protein
concentrations were approximately 50 times higher in the s-
Cath samples. A comparison of the protein concentration in
the lung fluid using different sampling techniques in the same
patients has not been previously done [26]. Our results using
s-Cath vs mini-BAL in the same patients suggest that the
mini-BAL method dilutes alveolar fluids by 16-fold as
compared with the s-Cath method.
To our knowledge, this is the first direct comparison of
the lung fluid samples obtained by s-Cath and mini-BAL.
Perkins et al. [20] compared mini-BAL to bronchoscopic
BAL and found that mini-BAL samples had an increased
ratio of bronchial epithelial cells to macrophages, suggesting
greater airway sampling. Furthermore, mini-BAL and bron-
choscopic BAL were poorly comparable as measured by
Bland–Altman analysis of total protein concentration and
other markers of alveolar inflammation [20]. Taken together,
the study by Perkins et al. and the results of our study
suggest that the lung fluid sampling technique that reflects
the alveolar contents to the greatest extent is bronchoscopic
BAL, followed by the mini-BAL and, finally, by the s-Cath.
This study has several limitations that must be considered in
interpreting the results. First, it is difficult to assess the
agreement between s-Cath and mini-BAL because the gold
standard, bronchoscopic BAL, was not included in the
experiment. We did not include bronchoscopy because
sequentially performing mini-BAL and bronchscopic BAL in
the same segment would not produce independent samples for
analysis. Other statistical tools that assess agreement, such as
the Bland–Altman analysis, are not compatible with the large
number of variables (protein spots) in proteomic analysis.
Thus, to quantitate the magnitude of difference seen between
the s-Cath and mini-BAL samples, we performed an over-
abundance analysis.
In the overabundance analysis, the expected number of
differentially expressed spots is likely to be an underestima-
tion because our calculated value does not account for several
factors that could increase the number of differentially
expressed spots even if the sampling techniques are equiva-
lent. First, the calculated value does not account for the
experimental variation in sample preparation, two-dimension-
al electrophoresis, and spot analysis. However, our control
experiment using identical s-Cath samples (Fig. 2) shows that
the variability in our experimental technique is minimal and
unlikely to account for the robust differences seen in the
overabundance analysis. Second, because both the s-Cath
and mini-BAL are performed blindly, it is possible that,
although s-Cath and mini-BAL are equivalent sampling
techniques, the variation in the samples in our study were the
result of different segments of the lung being sampled.
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Steinberg et al. [22] compared the protein concentration of
bronchoscopic BAL samples collected from the right and left
lung of patients with ARDS and showed that approximately
40% of patients had a side-to-side variability of twofold or
more as assessed by the Bland–Altman analysis. These
results suggest that lung fluids sampled from different parts
of the lung in the same patient are heterogeneous [22].
Despite the potential for heterogeneous sampling, previous
investigators have examined the location of blindly inserted
catheters that sample lung fluid and have found that they
almost always end up in the right lower lobe [20, 23].
Perkins at al. [20] obtained chest X-rays in 4 of 21 patients in
whom mini-BAL was performed and found that the catheter
invariably wedges in the right bronchial tree. In addition,
Pugin et al. [31] used the injection of radio-opaque contrast
material in the lungs to assess the position of the mini-BAL
catheter during a study of the characteristics of mini-BAL in
the diagnosis of ventilator-associated pneumonia. That study
also showed that the mini-BAL catheter generally wedges in
the distal right lower lobe. Although no investigators have
systematically studied the location of the s-Cath catheter
after blind insertion, the preferential sampling of the right
lower lobe likely applies to the s-Cath as well. Therefore,
most of the lung fluid samples obtained by s-Cath or mini-
BAL were likely to have been collected from the right lower
lobe. This, coupled with the consistent overabundance of
differentially expressed spots in all seven subjects, argues
against heterogeneous sampling as an explanation for the
differences seen between the s-Cath and mini-BAL samples.
Nevertheless, these confounding factors highlight the fact
that the calculated number of differentially expressed spots
represents an incomplete estimation of the number of spots
that would be different even if the s-Cath and mini-BAL
were equivalent. However, the robust differences in the
actual vs expected number of spots, as well as the
consistency in these differences across all subjects suggest
that the samples collected by s-Cath and mini-BAL differ in
some ways, although the majority of the recovered proteins
were the same.
Another caveat is that this proteomic analysis probably
captured only a subset of the overall lung fluid proteome.
Several classes of proteins are not well represented in our
proteomics dataset. Proteins with at the extremes of
isoelectric points (4>pI>7) or molecular weight [10>MW
(kDa)>200] are not likely to show on the analytical portion
of the 2D gel. Furthermore, extremely low-abundance
proteins, such as chemokines and cytokines, are typically
below the level of detection for the DIGE methodology.
Finally, proteins that are membrane-bound or hydrophobic
also are less likely to be detected by the DIGE methodology.
Despite these considerations, this proteomic analysis
using the DIGE method leads to a testable hypothesis that
can be explored in larger numbers of patients using
surrogate markers of airway sampling (such as the number
of bronchial epithelial cells) to confirm the results.
Conclusions
In summary, we have shown using a proteomic analysis
that, while the results of lung sampling by the s-Cath and
mini-BAL methods are generally similar, there are some
important differences. Analysis of the global protein
expression in these lung fluid samples suggests that the
differences occur because the s-Cath samples the bronchial
airways to a greater extent than the mini-BAL method.
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